Multimodal Intraoperative Neuromonitoring in Intradural Spinal Tumors: A Detailed Case Series Highlighting the Role of D‑Wave Monitoring

Why It Matters

D‑wave monitoring provides a reliable intraoperative biomarker for motor pathway integrity, enabling surgeons to adjust technique and improve patient outcomes. Its adoption could lower postoperative deficit rates across spine oncology centers.

Key Takeaways

• D‑wave amplitude predicts long‑term motor recovery.
• Multimodal IONM reduces intraoperative neurological risk.
• Transient MEP changes observed in majority of cases.
• Real‑time monitoring guides extent of tumor resection.
• Study limited to four retrospective cases.

Pulse Analysis

Intradural spinal tumor surgery presents a unique challenge: the dense arrangement of motor and sensory tracts leaves little margin for error. Multimodal intraoperative neuromonitoring—combining motor evoked potentials (MEP), somatosensory evoked potentials (SSEP), and D‑wave recordings—offers surgeons a real‑time map of functional integrity. While MEP and SSEP have long been standard, D‑wave monitoring captures direct corticospinal tract activity, delivering a more specific signal of motor pathway health. This granular feedback is increasingly recognized as a safeguard against irreversible injury during delicate tumor resections.

The case series examined four patients and found that transient MEP fluctuations occurred in three, yet those who maintained or recovered D‑wave amplitude experienced robust motor recovery at follow‑up. This correlation underscores D‑wave’s predictive power: a stable D‑wave often signals that the corticospinal tract remains intact, allowing surgeons to proceed with more aggressive resection without compromising function. Conversely, a declining D‑wave prompts immediate corrective actions, such as adjusting retraction or pausing dissection, thereby averting permanent deficits. The data, though limited, reinforce the notion that integrating D‑wave into the IONM suite enhances decision‑making precision.

Looking ahead, broader implementation of D‑wave monitoring could reshape spine oncology standards. Hospitals investing in advanced neuromonitoring platforms may see reduced postoperative morbidity, translating into shorter rehabilitation periods and lower overall care costs. However, widespread adoption hinges on specialized training, equipment costs, and standardized interpretation protocols. Ongoing multicenter trials are essential to validate these early findings and to define evidence‑based guidelines that balance maximal tumor removal with functional preservation. As the technology matures, D‑wave monitoring is poised to become a cornerstone of safe, high‑quality spinal tumor surgery.